Focal segmental glomerulosclerosis - Does treatment work? See Goumenos et al., pp. c75-c82

Nephron - Clinical Practice

Volumn 104, Issue 2, 2006, Pages

  Stirling, C M ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; FOLLOW UP; GLOMERULOSCLEROSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; NOTE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; REMISSION; SURVIVAL; TREATMENT DURATION;

AZATHIOPRINE; CLINICAL TRIALS; CYCLOSPORINE; DRUG COMBINATIONS; EVIDENCE-BASED MEDICINE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PREDNISOLONE; TREATMENT OUTCOME;

EID: 33749009568     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093994     Document Type: Note

References (13)

1. Haas M, Meehan SM, Karrison TG, Spargo BH: Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 1997;30:621-631.
2. Schena FP: Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. The Italian Group of Renal Immunopathology. Nephrol Dial Transplant 1997;12:418-426.
3. Korbet SM, Schwartz MM, Lewis EJ: Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis 1994;23:773-783.
4. Rydel JJ, Korbet SM, Borok RZ, Schwartz MM: Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment. Am J Kidney Dis 1995:25:534-542.
5. Cattran DC, Rao P: Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 1998;32:72-79.
6. Ponticelli C, Villa M, Banfi G, Cesana B, Pozzi C, Pani A, Passerini P, Farina M, Grassi C, Baroli A: Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis 1999:34:618-625.
7. Stirling CM, Mathieson P, Boulton-Jones JM, Feehally J, Jayne D, Murray HM, Adu D: Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units. QJM 2005;98:443-449.
8. Goumenos DS, Tsagalis G, El Nahas AM, Shortland JR, Davlouros P, Vlachojannis JG, Brown CB: Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: A five-year follow-up study. Nephron Clin Pract 2006;104:c75-c82.
9. Usta M, Ersoy A, Dilek K, Ozdemir B, Yavuz M, Gullulu M, Yurtkuran M: Efficacy of losartan in patients with primary focal segmental glomerulosclerosis resistant to immunosuppressive treatment. J Intern Med 2003;253:329-334.
10. Korbet SM: Treatment of primary focal segmental glomerulosclerosis. Kidney Int 2002;62:2301-2310.
11. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC: Toronto Glomerulonephritis Registry Group. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol 2005;16:1061-1068.
12. Segarra A, Vila J, Pou L, Majo J, Arbos A, Quiles T, Piera LL: Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up. Nephrol Dial Transplant 2002;17:655-662.
13. Cattran DC, Wang MM, Appel G, Matalon A, Briggs W: Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis. Clin Nephrol 2004;62:405-411.